Familial adenomatous polyposis (FAP) is an autosomal dominant illness with the highest risk for appearance of colorectal cancer's disease. In our study, we have used Bethesda criteria that defi ne colorectal cancers which can be tested on microsatellite instability. Th e aim of our study is make an analysis of microsatellite instability (MSI), appearance of RER+ phenotype, genetic alteration of tumor suppressor genes as like as one of responsible factor for genesis of adenomatous polyposis. Th e base for this study were shown families with clinical diagnosed FAP. In this study two families with clinical diagnosed adenomatous polyposis were involved. Our study of both families showed that three tumor tissues belonged to RER negative phenotype, but only one belonged to RER positive phenotype. Microsatellite analysis showed instability of mononucleotide marker Bat  at  samples and Bat  at  samples, but Bat  and in  sample. Dinucleotide marker TP  did no show any microsatellite alterations. Genetic alteration of tumor suppressor gene APC appeared at  samples, p at  samples, RB at  samples and NM only at  sample, but tumor suppressor genes DCC and DCC were homozygote. Our results are agree with results of earlier studies and also the got results confi rm the fact that loss of heterozygosity of tumor suppressor gene APC and p are responsible for genesis of adenomatous polypose and it also represents the characteristic of genetic changes FAP' s patients in our region.
Introduction
Familial adenomatous polyposis (FAP) is an autosomal dominant illness with the highest risk for appearance of colorectal cancer's disease () ; which is appeared in over  of unoperated cases. This illness is characteristic of forming with over , usually about  polyps of colorectal cancer and often with stomach's adenoma as like as small intestine's stomach. Th e biggest number of persons with FAP illness get the colorectal cancer before their  year old. The illness frequency is ,:  . The illness is hereditary on descendants in  of its cases, but it can get sick and more generations in a family. Oftentimes FAP is caused by mutation of APC gene. Persons with hereditary mutated APC gene have a high risk for developing of adenoma in their childhood, so that estimated risk is over . Some cancers show p mutation before APC mutation. Usually, loss of heterozygosity which is appeared at colorectal cancers through the FAP's frame is appeared on hromosomes , , ,  and . Th is point has showed localization of tumor suppressor genes. It seems that the illness of males is some often that the illness of females ( : ). There is no positive history of the illness in  of diagnosed cases. Defect of MMR gene leads to high level of microsatelites instability (MSI-H) in tumor tissue. So that the microsatellites instability can be found in early stage of the adenoma. It is known that a full develop of a microsatelites mutator phenotype can depend and on accumulation of secondary mutations () . The microsatellite instability is established in  adenoma of hereditary non-polyposis colorectal cancer, and even , belongs to MSI-H () . Th at investigation in this group of MSI-L levels show that there is a relation commonly with loss of hMLH or hMSH expression, and what is diff erent to situation with MSI-L of sporadic colorectal cancers. According to authors, this phenomenon that MSI-L status is appeared perhaps in earlier phase is in relation with dinucleotide markers. Authors also conclude that adenomas of MSI-H status must pass through phase of MSI-L stage or how it is cited perhaps MSI-H phenotype can give a ''de novo'', and what is unknown in this moment yet. It seems that MSI-L can be appeared in evolution of MSI-H earlier at HNPCC or MSI-L, and MSI-H can be with split phenotypes as like as at sporadic colorectal cancers. Authors also concluded that there are no a signifi cant relation among MSI status, sex, years and cancer location () . Other authors show in own research works that MSI status is in r ank of - (-) . Usage of these  dinucleotide markers gave results in appearance of low percent detected mutation in microsatellite loci at benigne adenoma than at adenomas which have had alteration on malignancy () . Th ere is relation among MSI-H adenomas and loss of MMR expression at colorectal cancers. It seems that MSI-H adenomas have more tendency to developing of cancers () . In our study, we have used Bethesda criteria that define colorectal cancers which can be tested on microsatellite instability () . According to these criterias, there is a cancers classifi cation on microsatellite instability as like as following:
• -MSI -L -microsatellite instability-low (MSI in locus less than - ); • -MSI-H -microsatellite instability-high (MSI in locus more than  and replication positive error (RER+) and • -MSS cancers-microsatellite stable The aim of our study is make an analysis of microsatellite instability (MSI), appearance of RER+ phenotype, genetic alteration of tumor suppressor genes as like as one of responsible factor for genesis of adenomatous polyposis. Th e base for this study were shown families with clinical diagnosed FAP.
Materials and Methods
Th rough the study we involved two families with clinical diagnosed adenomatous polyposis and samples were collected from Gastroenterological of University Clinical Center in Tuzla (Bosnia and Herzegovina). Tumor's and healthy surroundings tissue were fixed in formalin, and after that tissue was shaped in paraffi n blocks. Methods of isolation of genomic DNA is made on deparaffinization of tissue sections as like as on cell proteolises of tissue by proteinase K. () Fluoroscent chain synthesis of DNA is a method which has very broad application in tumor detection, and it is specially important in determination of microsatellite instability (MSI) and loss of heterozygosity (LOH) of tumor suppressor gene. We used mononucleotide and dinucleotide microsatellite markers in detection of microsatellite instability. We used in the group of mononucleotide markers following: BAT, BAT and BAT, but in the group of dinucleotide markers we used following: DS and TP . for detection of LOH, we used intragene markers for following tumor suppressor genes: NM, p, APC, RB, DCC and DCC.() PCR was performed using a PCR Th ermocycler  (Perkin-Elmer). The PCR conditions were as follows: after an initial  min denaturation step at °C,  (Table ) .
Discussion
Accepted fact is that familial adenomatous polypose is a form of colon tumor, which is caused by mutation of tumor suppressor APC gene. Th e risk for cancer developing is  if detected polypes are not removed in time () . Authors concluded that mutations of APC gene have main role in early development of colorectal neoplasmas. It is also concluded that  of colorectal tumors as like as  of adenomas have mutation in APC gene () . APC mutation exists in earlier stages of tumor development. Sequence analysis showed that the highest number of adenomas as like as cancers have APC mutation () .  APC mutation exists in earlier stages tumor development. Loss of APC gene is found at  adenoma of FAP patients () . RER tumor phenotype involves  adenomas and  cancers. From RER positive tumors only  showed mutation of APC locus, p as like as loss of heterozygosity which had signifi cantly less frequency. Authors conclude that RER positive phenotype comes in late phases and that tumors pass diff erent changes in adenoma to carcinoma sequence what make a high percent of development of APC mutation. () . Researching of germline mutation show that  of patients have exist mutation of APC gene () . Different germline mutations in APC locus exist in  samples of Finnish families () . Families without detected APC mutation differentiate on the families having mutation. The difference involves following: age of diagnosis making was high (about  ages) and expression of extra colonal illness' was also high. Authors cite a significant of predicative tests on mutation at positive families and they stimulate further analysis of mutation at negative families. Appearances of low frequently colon cancers can be described as an unusal occurrence of "second hit" which is necessary for polyp developing or it is low occurrence of APC locus mutation () .
Mutation in the region of APC tumor suppressor was researched in Czechs populations () . APC mutations researched at  FAP families and  ''possible'' FAP families. Authors have found  germline mutations of APC locus. Many colon cancer syndromes have been characterized based upon their phenotype genetic changes. Among them, the most common and highly studied colon can familial adenomatous polyposis and hereditary nonpolyposis colorectal which are caused by mutations in APC and MMR genes, respectively () . Mutation in APC locus are considered as one the initiation and progression of colorectal cancer. Our study of both families showed that three tumor tissues belonged to RER negative phenotype, but only one belonged to RER positive phenotype. Microsatellite analysis showed instability of mononucleotide marker Bat  at  samples and Bat  at  samples, but Bat  and in  sample. Dinucleotide marker TP  did no show any microsatellite alterations. Genetic alteration of tumor suppressor gene APC appeared at  samples, p at  samples, RB at  samples and NM only at  sample, but tumor suppressor genes DCC and DCC were homozygote. Microsatellite analysis and genetic alteration all members of FAP's Families ''A'' and ''B'' with developed colorectal cancer have shown the identical changes as like as at the cancer.
Conclusion
Our results are agree with results of earlier studies and also the got results confi rm the fact that loss of heterozygosity of tumor suppressor gene APC and p are responsible for genesis of adenomatous polypose and it also represents the characteristic of genetic changes FAP's patients in our region. 
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